A quick peek into the report
Europe Companion Diagnostics Market
Focus on Application, End User, Technology, and Country - Analysis and Forecast, 2023-2033
Frequently Asked Questions
The global companion diagnostics market was valued at $3,762.0 million in 2023 and is expected to reach $12,498.7 million by 2033, growing at a CAGR of 12.76% between 2023 and 2033.
A companion diagnostic (CDx) is a specialized in vitro diagnostic (IVD) test that identifies patients most likely to benefit from a specific therapy, particularly in personalized medicine. In contrast, IVDs are broader diagnostic tools used to detect diseases or health conditions without being linked to a specific treatment.
The Europe companion diagnostics report gives a detailed analysis of all aspects of the market. This can be useful to manufacturers, service providers, and any of the end users to make informed decisions and enable targeted marketing, strategic planning, product benchmarking, and better resource allocation, among other things.
The following are the USPs of this report:
• Market regulations and a list of key trends in the Europe companion diagnostics market
• A competitive index of the market specific to the unmet needs and innovations of the key players
• Key challenges faced by manufacturers
• Market dynamic analysis of the opportunities, trends, and challenges in the market
• Competitive benchmarking of key players for each product type